Cargando…
Mifepristone Repurposing in Treatment of High-Grade Gliomas
Glioma is the most common and aggressive primary tumor of the central nervous system. The standard treatment for malignant gliomas is surgery followed by chemoradiotherapy. Unfortunately, this treatment has not produced an adequate patient response, resulting in a median survival time of 12–15 month...
Autores principales: | Llaguno-Munive, Monserrat, Vazquez-Lopez, Maria Ines, Jurado, Rafael, Garcia-Lopez, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930566/ https://www.ncbi.nlm.nih.gov/pubmed/33680961 http://dx.doi.org/10.3389/fonc.2021.606907 |
Ejemplares similares
-
Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2020) -
Corrigendum: Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2021) -
Mifepristone improves chemo-radiation response in glioblastoma xenografts
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2013) -
Pharmacokinetics and Anti-Tumor Efficacy of PEGylated Liposomes Co-Loaded with Cisplatin and Mifepristone
por: Ocaña-Arakachi, Karen, et al.
Publicado: (2023) -
The Therapeutic Potential of Chemo/Thermotherapy with Magnetoliposomes for Cancer Treatment
por: Toro-Córdova, Alfonso, et al.
Publicado: (2022)